Back to Jobs
Kailera Therapeutics
Engineering & Architecture 14h ago

Vice President, Global Supply Chain

Kailera Therapeutics
United StatesUnited States
Hybrid
$272,000 - $340,000 USD
Senior-Level
VT

Does Kailera Therapeutics sponsor H-1B visas?

Check real filing data, salaries & approval rates on VisaTalentUSA

View Data →

Job Description

Key Skills Required

Master these to land this role

AI-enabled ToolsGlobal LogisticsSupply Chain ManagementERP SystemsRegulatory Compliance

Want to know if you're a match for this job?

Calculate My Match Score

At Kailera, we are bold, authentic, and committed to developing therapies that empower individuals to transform their lives and enhance overall health. Rooted in an entrepreneurial spirit and a team-oriented culture, we are advancing novel therapies for obesity and related conditions.

What You’ll Do:

Reporting to the Chief Technology Officer (CTO), the Vice President (VP), Global Supply Chain will lead Kailera’s end-to-end clinical and commercial supply chain, ensuring patients and clinical sites receive a reliable, uninterrupted supply of both Investigational Medicinal Product (IMP) and commercial drug product. This leader will set the global supply strategy, build and develop a high-performing team, and establish strong, well-governed partnerships with external service providers.

Working closely with CMC, Clinical, Regulatory, Quality, Commercial, and Corporate functions, the VP will ensure supply plans meet global quality and regulatory standards and scale with the company’s growth. As a senior member of the Technical Operations leadership team, this individual will partner with the CTO to shape and sustain a culture of collaboration, accountability, and operational excellence.

Required location: Waltham, MA (hub-based, onsite 3-4 days per week) OR Remote (home-based, onsite at a hub 1 week every other month).

Responsibilities:

  • Recruit, develop, and retain a strong global supply chain organization. Establish clear governance structures and performance metrics for tracking and reporting
  • Manage performance of external partners, including packaging and labeling vendors, third-party logistics providers (3PLs), and distributors, API and device suppliers, through governance meetings, quality and supply agreements, and KPI dashboards
  • Establish global logistics and distribution, including cold chain management where applicable, import/export and trade compliance, and supply to international markets through direct distribution, partners, or named patient/early access programs
  • Ensure supply chain operations comply with GMP/GDP and global regulatory requirements, including FDA, EMA, EU Annex 13, QP release, and serialization requirements such as DSCSA and EU FMD
  • Lead selection, implementation, and optimization of supply chain systems (e.g., ERP, IRT/RTSM, and supply planning tools) to improve visibility and forecasting accuracy
  • Accountable for establishing compliant and effective clinical and commercial supply chain processes and driving operational excellence across the SCM organization
  • Coordinate cross-functional efforts across CMC, Legal, Procurement, Commercial, Regulatory, Clinical Development, and Clinical Operations to ensure reliable drug supply delivery
  • Develop a best-in-class sourcing/procurement organization and coordinate with cross-functional teams to drive enterprise-wide cost optimization initiatives
  • Apply market insights and modern digital and AI-enabled tools across sourcing and supply planning for greater visibility, better decision-making, and a supply chain that can scale efficiently
  • Design and implement strategic plans to supply drug to complex global clinical trials and commercial markets using robust, industry-leading supply chain practices
  • Develop and manage the supply chain budget, and track performance against key metrics such as service level, inventory health, forecast accuracy, and write-offs

Required Qualifications:

  • 15+ years of relevant biopharmaceutical industry experience, including clinical supply management and commercial supply chain
  • Extensive experience managing multiple complex global supply chain operations for development-stage and commercial products covering Plan, Source, Make, and Deliver
  • Direct involvement in at least one commercial product launch in the US and/or international markets
  • Proven people leadership experience, including building, scaling, and developing high-performing teams at the Director level or above
  • Working knowledge of GMP/GDP, global clinical and commercial regulatory requirements, and serialization/track-and-trace requirements
  • Experience with S&OP processes, supply planning, and supply chain systems such as ERP (e.g., SAP) and IRT/RTSM
  • Ability to build a collaborative environment and manage multiple projects with global CDMOs
  • Strong executive presence and the ability to influence senior leadership and external partners on supply strategy and risk
  • Hands-on, roll-up-your-sleeves, collaborative approach with a high sense of urgency and drive for results
  • Ability to think creatively and challenge the status quo
  • Desire to work in a fast-paced, innovative environment
  • Local candidates are strongly preferred; relocation and remote talent will be considered. Remote employees must adhere to the Hub & Home working model, including a minimum of one week per month in the Waltham, MA corporate office (in addition to any other work-related travel), with overall work-related travel estimated at least 25%

Preferred Qualifications:

  • Prior experience at a late clinical-stage biotechnology company transitioning toward commercial launch, including launch readiness and post-approval supply chain management
  • Experience scaling a global supply chain function from a lean, pre-commercial organization

Education:

A Bachelor’s degree in pharmaceutical science, biology, life sciences, or another relevant field; an advanced degree (MS, MBA, PharmD, or PhD) and/or APICS/ASCM certification is preferred.

How would you rate this job post?

See what other professionals think about this role.

banner
logo

Kailera Therapeutics

View Company Profile

Kailera Therapeutics is the premier, enterprise-grade clinical-stage biotechnology pioneer, multi-receptor incretin therapy innovator, and metabolic healthcare powerhouse engineered to operate as the definitive, high-velocity developer layer for next-generation obesity and cardiometabolic disease treatments globally. The company completely eliminates the severe systemic friction of modern weight-management therapeutics—where first-generation single-receptor treatments face commercial efficacy ceilings, plateaus in total body weight loss, injection delivery barriers, and challenging gastrointestinal side effects—by deploying an advanced, multi-pronged incretin and small-molecule discovery platform. Moving far beyond traditional, passive disease research models or isolated chemical formulation screening, Kailera natively unifies once-weekly injectable dual-agonist peptides (ribupatide/KAI-9531 targeting GLP-1 and GIP), highly differentiated once-daily oral small-molecule alternatives, and next-generation triple-agonist (triple-G) programs (KAI-4729 targeting GLP-1, GIP, and glucagon receptors) into a unified, high-conviction clinical portfolio. Launched via a record-shattering $625 million initial public offering (IPO) on the Nasdaq Stock Market (NASDAQ: KLRA) that bypassed typical early biotech capital constraints, the firm maintains an expansive financial run-rate to advance its broad global Phase 2b and Phase 3 KaiNETIC clinical development tracks with production-hardened scientific precision. Under the hood, its sophisticated technical practice leverages exclusive ex-China asset licenses from global pharmaceutical giant Jiangsu Hengrui, running automated high-throughput data pipelines, rigorous multi-tenant patient trial monitoring frameworks, and strict FDA and global health authority compliance structures. What sets Kailera Therapeutics apart is its uncompromising dedication to replacing mechanical treatment protocols with absolute therapeutic options and long-term metabolic health momentum; by bridging the gap between performance-intensive big data receptor analytics and convenient, highly tolerable patient-centric treatments, the institution remains the definitive, category-defining cornerstone of modern incremental weight loss and metabolic clinical innovation.

Safety First

  • Never pay for a job application.
  • Do not share sensitive bank info.
  • Verify the client before starting work.
Learn More
Vice President, Global Supply Chain at Kailera Therapeutics | HireSkys